Results 111 to 120 of about 349,007 (339)

Risk of Infections with SGLT2 Inhibitors Versus DPP4 Inhibitors: A Population‐Based Cohort Study Using Antibiotic Dispensing Data

Clinical Pharmacology &Therapeutics, EarlyView.
This study compared the number and cumulative dose of antibiotic dispensings among new users of sodium–glucose cotransporter‐2 (SGLT2) inhibitors and dipeptidyl peptidase‐4 (DPP4) inhibitors following hospital discharge in individuals with type 2 diabetes.
Maria J. Alfonso Arvez, George S. Q. Tan, Sam Wade, Zanfina Ademi, Jenni Ilomäki, J. Simon Bell   +5 more
wiley   +1 more source

Are estimates of socioeconomic inequalities in chronic disease artefactually narrowed by self-reported measures of prevalence in low-income and middle-income countries? Findings from the WHO-SAGE survey [PDF]

, 2014
Background: The use of self-reported measures of chronic disease may substantially underestimate prevalence in low-income and middle-income country settings, especially in groups with lower socioeconomic status (SES).
Aitsi-Selmi, A., Basu, S, Ebrahim, S, Khan, Z., Millett, C., Stuckler, D, Vellakkal, S.   +6 more
core   +2 more sources

Effectiveness and Safety of Reduced‐Dose Prasugrel in an East Asian Population: PRASFIT‐ACS Emulation Using National Health Insurance Claims Data

Clinical Pharmacology &Therapeutics, EarlyView.
Prasugrel is recommended for acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI). However, East Asians exhibit a stronger antiplatelet response, raising concerns about bleeding risks with standard dosing. This retrospective cohort study evaluated the real‐world effectiveness and safety of reduced‐dose prasugrel in
Li‐Wen Huang, Yee‐Jen Wu, Fang‐Ju Lin, Chien‐Chih Wu, Hsin‐Yi Huang, Chi‐Chuan Wang, Xiaojuan Li   +6 more
wiley   +1 more source

CLOPIDOGREL FOR SELECTIVE MYOCARDIAL REVASCULARIZATION

Российский кардиологический журнал, 2016
The article focuses on the practical issues of selective revascularization of myocardium, including the specifics of procedure and patients characteristics, whom this intervention is at most indicated.
N. V. Teplova
doaj   +1 more source

Results of Aortocoronary Bypass Surgery for Angina Pectoris [PDF]

, 1979
To determine the relative risks and benefits of coronary bypass surgery for angina pectoris, we examined the results in our first consecutive 360 patients operated upon between May 1970 and December 1975.
Kemp, V. Eric, Lower, Richard R., Szentpetery, Szabolcs, Wolfgang, Timothy   +3 more
core   +1 more source

Carboxyhaemoglobin levels and their determinants in older British men [PDF]

, 2006
Background: Although there has been concern about the levels of carbon monoxide exposure, particularly among older people, little is known about COHb levels and their determinants in the general population.
A Malanca, AG Shaper, Andrew Haines, BD Cox, C Borland, CJ Dore, CL Hart, CL Townsend, DN Leitch, DR Rowe, EN Allred, EP Radford, Institute for Environment and Health, J Critchley, JH Mennear, JH Schulte, Lucy Lennon, MC Thomas, MR Law, MT Kleinman, N Wald, Olia Papacosta, Peter Whincup, RA Myers, RD Morris, RT Burnett, SR Thom, VR Putz, World Health Organization, WS Aronow, Y Amitai   +30 more
core   +3 more sources

Emulating Six Cardiovascular Outcome Trials of Antidiabetic Drugs in Individuals with Type 2 Diabetes: Analyses Based on Real‐World Databases from Korea and Taiwan

Clinical Pharmacology &Therapeutics, EarlyView.
With the increasing volume of clinical evidence derived from large‐scale Asian real‐world data (RWD) and the growing interest in its use in regulatory decision‐making, it is important to conduct benchmarking exercises that evaluate whether studies using Asian RWD can generate similar conclusions as randomized controlled trials (RCTs).
Hwa Yeon Ko, Philip C. M. Au, Michael Chun‐Yuan Cheng, Ching‐Lung Cheung, Ahhyung Choi, Miyuki Hsing‐Chun Hsieh, Han Eol Jeong, Edward Chia‐Cheng Lai, Brian Meng‐Hsun Li, Kenneth K. C. Man, Jeremy A. Rassen, Daniel Hsiang‐Te Tsai, Shirley V. Wang, Ian C. K. Wong, Ju‐Young Shin, Sohee Park   +15 more
wiley   +1 more source

The Prevalence and Epidemiological Features of Ischaemic Heart Disease in Sri Lanka

Global Heart
Background: There is limited evidence on the prevalence of ischaemic heart disease (IHD) and its association with risk factors and socioeconomic status (SES) in low- and middle-income countries (LMICs).
Nilmini Wijemunige, Ravindra P. Rannan-Eliya, H. M. M. Herath, Owen O’Donnell   +3 more
doaj   +1 more source

Coronary-artery bypass surgery in patients with ischemic cardiomyopathy [PDF]

, 2016
BACKGROUND The survival benefit of a strategy of coronary-artery bypass grafting (CABG) added to guideline-directed medical therapy, as compared with medical therapy alone, in patients with coronary artery disease, heart failure, and severe left ...
Cox DR, Eric J. Velazquez, George Sopko, Hussein R. Al-Khalidi, Jae K. Oh, James A. Hill, Jean L. Rouleau, Julio A. Panza, Kerry L. Lee, Lilin She, Mark C. Petrie, Muhlbaier LH, Patrice Desvigne-Nickens, Qiu P, Robert E. Michler, Robert H. Jones, Robert O. Bonow, Topkara VK, Torsten Doenst, Vanessa L. Moore   +19 more
core   +1 more source

Impact of Antihypertensive Treatment on Outcomes of Adjuvant Bevacizumab for Ovarian Cancer (IATRO), Results from a Nationwide Emulated Clinical Trial

Clinical Pharmacology &Therapeutics, EarlyView.
Antiangiogenic therapy with bevacizumab improves outcomes in ovarian cancer but induces hypertension, leading to major adverse cardiovascular events (MACE). While calcium channel blockers (CCBs) and angiotensin‐converting enzyme inhibitors (ACEi) are recommended for managing bevacizumab‐associated hypertension, their impacts on cancer progression and ...
Floriane Jochum, Élise Dumas, Joe‐Elie Salem, Stéphane Ederhy, Anne‐Sophie Hamy, Lise Lecointre, Enora Laas, Fabien Reyal, Fabrice Lecuru, Cherif Akladios, Paul Gougis   +10 more
wiley   +1 more source